The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysophosphatidic Acid Stimulates the G-protein-coupled Receptor EDG-1 as a Low Affinity Agonist
Lee, M.-J., Thangada, S., Liu, C. H., Thompson, B. D., & Hla, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.22105 · Cited by 109
RetractedAstrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Kappos, L., Radue, E.-W., O'Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909494 · Cited by 2,644
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Summary of product characteristics
(2013) · Pharmaceutical Medicine · doi:10.1093/med/9780199609147.003.0027 · Cited by 1,905
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155 · cited 5×
“In EAE, BG-12 treatment led to reduced loss of neurons and glia in the CNS [180].”
InfluentialSphingosine-1-phosphate signaling and its role in disease
Maceyka, M., Harikumar, K. B., Milstien, S., & Spiegel, S. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.003 · Cited by 1,039 · cited 1×
“Sphingosine 1-phosphate (S1P), a naturally occurring lipidmediator and part of the larger family of lysophospholipids, can act as a regulator of diverse physiological and pathophysiological processes, including those involved in the pathogenesis of multiple sclerosis (MS) [1–3].”
Lee, M.-J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. I., & Hla, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81661-x · Cited by 1,013
Regulation of Gliogenesis in the Central Nervous System by the JAK-STAT Signaling Pathway
Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D. A., Rozovsky, I., Stahl, N., Yancopoulos, G. D., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.278.5337.477 · Cited by 1,013
Sphingosine-1-Phosphate as a Ligand for the G Protein-Coupled Receptor EDG-1
Lee, M.-J., Van Brocklyn, J. R., Thangada, S., Liu, C. H., Hand, A. R., Menzeleev, R., Spiegel, S., & Hla, T. (1998) · Science · doi:10.1126/science.279.5356.1552 · Cited by 1,007
Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y.-W., Huang, Y., Cyster, J. G., et al. (2007) · Science · doi:10.1126/science.1139221 · Cited by 877
Primary-progressive multiple sclerosis
Miller, D. H., & Leary, S. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70243-0 · Cited by 818
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Chun, J., & Hartung, H.-P. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181cbf825 · Cited by 796 · cited 13×
“Additionally, activation of S1P5 by fingolimod impeded spontaneous migration of cultured neonatal rat OPCs [49], but fingolimod did not inhibit OPC migration when platelet-derived growth factor was used as a chemoattractant [92].”
InfluentialSelf-citationLysophospholipid Receptors: Signaling and Biology
Ishii, I., Fukushima, N., Ye, X., & Chun, J. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073731 · Cited by 771
Self-citationEssential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742
Hecht, J. H., Weiner, J. A., Post, S. R., & Chun, J. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.4.1071 · Cited by 720
Self-citationAstrocytes and disease: a neurodevelopmental perspective
Molofsky, A. V., Krenick, R., Ullian, E., Tsai, H.-H., Deneen, B., Richardson, W. D., Barres, B. A., & Rowitch, D. H. (2012) · Genes & Development · doi:10.1101/gad.188326.112 · Cited by 682
Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K., Poulton, S., Milstien, S., Kohama, T., & Spiegel, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002759200 · Cited by 667
Astrocyte–neuron metabolic relationships: for better and for worse
Allaman, I., Bélanger, M., & Magistretti, P. J. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.12.001 · Cited by 639
Choi, J. W., Gardell, S. E., Herr, D. R., Rivera, R., Lee, C.-W., Noguchi, K., Teo, S. T., Yung, Y. C., Lu, M., Kennedy, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014154108 · Cited by 581
Self-citationThe immunosuppressant FTY720 down‐regulates sphingosine 1‐phosphate G protein‐coupled receptors
Gräler, M. H., & Goetzl, E. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-0910fje · Cited by 539
Molecular Cloning and Functional Characterization of Murine Sphingosine Kinase
Kohama, T., Olivera, A., Edsall, L., Nagiec, M. M., Dickson, R., & Spiegel, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23722 · Cited by 535
Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid
An, S., Bleu, T., Hallmark, O. G., & Goetzl, E. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.7906 · Cited by 528
Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling
Inoue, M., Rashid, M. H., Fujita, R., Contos, J. J. A., Chun, J., & Ueda, H. (2004) · Nature Medicine · doi:10.1038/nm1060 · Cited by 520
Self-citationWANG, D., & BORDEY, A. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.015 · Cited by 502
Protective Effects of Sphingosine 1-Phosphate in Murine Endotoxin-induced Inflammatory Lung Injury
Peng, X., Hassoun, P. M., Sammani, S., McVerry, B. J., Burne, M. J., Rabb, H., Pearse, D., Tuder, R. M., & Garcia, J. G. N. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1258oc · Cited by 495
Requirement for the lp A1 lysophosphatidic acid receptor gene in normal suckling behavior
Contos, J. J. A., Fukushima, N., Weiner, J. A., Kaushal, D., & Chun, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13384 · Cited by 479
Self-citationScannevin, R. H., Chollate, S., Jung, M.-Y., Shackett, M., Patel, H., Bista, P., Zeng, W., Ryan, S., Yamamoto, M., Lukashev, M., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190132 · Cited by 461
The measurement and clinical relevance of brain atrophy in multiple sclerosis
Bermel, R. A., & Bakshi, R. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70349-0 · Cited by 456
Oo, M. L., Thangada, S., Wu, M.-T., Liu, C. H., Macdonald, T. L., Lynch, K. R., Lin, C.-Y., & Hla, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610318200 · Cited by 405
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis
Cohen, J. A., & Chun, J. (2011) · Annals of Neurology · doi:10.1002/ana.22426 · Cited by 393
Self-citationImaging outcomes for neuroprotection and repair in multiple sclerosis trials
Barkhof, F., Calabresi, P. A., Miller, D. H., & Reingold, S. C. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.41 · Cited by 378
Sanchez, T., Estrada-Hernandez, T., Paik, J.-H., Wu, M.-T., Venkataraman, K., Brinkmann, V., Claffey, K., & Hla, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306896200 · Cited by 374
Evidence that Embryonic Neurons Regulate the Onset of Cortical Gliogenesis via Cardiotrophin-1
Barnabé-Heider, F., Wasylnka, J. A., Fernandes, K. J. L., Porsche, C., Sendtner, M., Kaplan, D. R., & Miller, F. D. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.037 · Cited by 362
Extracellular and Intracellular Actions of Sphingosine-1-Phosphate
Strub, G. M., Maceyka, M., Hait, N. C., Milstien, S., & Spiegel, S. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-6741-1_10 · Cited by 355
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
Mehling, M., Brinkmann, V., Antel, J., Bar-Or, A., Goebels, N., Vedrine, C., Kristofic, C., Kuhle, J., Lindberg, R. L. P., & Kappos, L. (2008) · Neurology · doi:10.1212/01.wnl.0000327609.57688.ea · Cited by 345
Wilms, H., Sievers, J., Rickert, U., Rostami-Yazdi, M., Mrowietz, U., & Lucius, R. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-30 · Cited by 344
Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival
Jaillard, C., Harrison, S., Stankoff, B., Aigrot, M. S., Calver, A. R., Duddy, G., Walsh, F. S., Pangalos, M. N., Arimura, N., Kaibuchi, K., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4645-04.2005 · Cited by 338
Adams, R. A., Bauer, J., Flick, M. J., Sikorski, S. L., Nuriel, T., Lassmann, H., Degen, J. L., & Akassoglou, K. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061931 · Cited by 335
Foster, C. A., Howard, L. M., Schweitzer, A., Persohn, E., Hiestand, P. C., Balatoni, B., Reuschel, R., Beerli, C., Schwartz, M., & Billich, A. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127183 · Cited by 322
Fukushima, N., Ishii, I., Contos, J. J., Weiner, J. A., & Chun, J. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.507 · Cited by 322
Self-citationContos, J. J. A., Ishii, I., Fukushima, N., Kingsbury, M. A., Ye, X., Kawamura, S., Brown, J. H., & Chun, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6921-6929.2002 · Cited by 316
Self-citationGergely, P., Nuesslein‐Hildesheim, B., Guerini, D., Brinkmann, V, Traebert, M., Bruns, C., Pan, S., Gray, N., Hinterding, K., Cooke, N., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02061.x · Cited by 305
Lysophospholipid G Protein-coupled Receptors
Anliker, B., & Chun, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400013200 · Cited by 284
Self-citationEdsall, L. C., Pirianov, G. G., & Spiegel, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-18-06952.1997 · Cited by 275
Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain Injury
Zhao, J., Moore, A. N., Redell, J. B., & Dash, P. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1683-07.2007 · Cited by 274
Ishii, I., Friedman, B., Ye, X., Kawamura, S., McGiffert, C., Contos, J. J. A., Kingsbury, M. A., Zhang, G., Brown, J. H., & Chun, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104441200 · Cited by 272
Self-citationCuzner, M. L., & Opdenakker, G. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00241-0 · Cited by 268
Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
Miron, V. E., Ludwin, S. K., Darlington, P. J., Jarjour, A. A., Soliven, B., Kennedy, T. E., & Antel, J. P. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091234 · Cited by 267
Shirani, A., Zhao, Y., Karim, M. E., Evans, C., Kingwell, E., van der Kop, M. L., Oger, J., Gustafson, P., Petkau, J., & Tremlett, H. (2012) · JAMA · doi:10.1001/jama.2012.7625 · Cited by 263
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
Zivadinov, R., Reder, A. T., Filippi, M., Minagar, A., Stüve, O., Lassmann, H., Racke, M. K., Dwyer, M. G., Frohman, E. M., & Khan, O. (2008) · Neurology · doi:10.1212/01.wnl.0000316810.01120.05 · Cited by 260
Deogracias, R., Yazdani, M., Dekkers, M. P. J., Guy, J., Ionescu, M. C. S., Vogt, K. E., & Barde, Y.-A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206093109 · Cited by 256
FTY720 modulates human oligodendrocyte progenitor process extension and survival
Miron, V. E., Jung, C. G., Kim, H. J., Kennedy, T. E., Soliven, B., & Antel, J. P. (2008) · Annals of Neurology · doi:10.1002/ana.21227 · Cited by 255
Lysophospholipids and their receptors in the central nervous system
Choi, J. W., & Chun, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.015 · Cited by 255
Self-citationSchwann cell survival mediated by the signaling phospholipid lysophosphatidic acid
Weiner, J. A., & Chun, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5233 · Cited by 251
Self-citationNon-proliferative effects of lysophosphatidic acid enhance cortical growth and folding
Kingsbury, M. A., Rehen, S. K., Contos, J. J. A., Higgins, C. M., & Chun, J. (2003) · Nature Neuroscience · doi:10.1038/nn1157 · Cited by 250
Self-citationThe Metabolism of Sphingomyelin
Kanfer, J. N., Young, O. M., Shapiro, D., & Brady, R. O. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96805-5 · Cited by 248
Stahl, N., & Yancopoulos, G. D. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251111 · Cited by 246
Identification of cDNAs encoding two G protein‐coupled receptors for lysosphingolipids1
An, S., Bleu, T., Huang, W., Hallmark, O. G., Coughlin, S. R., & Goetzl, E. J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01301-x · Cited by 244
Ishii, I., Ye, X., Friedman, B., Kawamura, S., Contos, J. J. A., Kingsbury, M. A., Yang, A. H., Zhang, G., Brown, J. H., & Chun, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200137200 · Cited by 244
Self-citationSerum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
Waubant, E., Goodkin, D. E., Gee, L., Bacchetti, P., Sloan, R., Stewart, T., Andersson, P.-B., Stabler, G., & Miller, K. (1999) · Neurology · doi:10.1212/wnl.53.7.1397 · Cited by 234
Graeler, M., & Goetzl, E. J. (2002) · The FASEB Journal · doi:10.1096/fj.02-0548com · Cited by 230
Webb, M., Tham, C.-S., Lin, F.-F., Lariosa-Willingham, K., Yu, N., Hale, J., Mandala, S., Chun, J., & Rao, T. S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.04.015 · Cited by 226
Self-citationKataoka, H., Sugahara, K., Shimano, K., Teshima, K., Koyama, M., Fukunari, A., & Chiba, K. (2005) · PubMed · Cited by 216
Ishii, I., Contos, J. J. A., Fukushima, N., & Chun, J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12460-1 · Cited by 214
Self-citationSorensen, S. D., Nicole, O., Peavy, R. D., Montoya, L. M., Lee, C. J., Murphy, T. J., Traynelis, S. F., & Hepler, J. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1199 · Cited by 210
Sphingosine‐1‐phosphate induces proliferation and morphological changes of neural progenitor cells
Harada, J., Foley, M., Moskowitz, M. A., & Waeber, C. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02219.x · Cited by 203
Sphingosine 1‐phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions
Van Doorn, R., Van Horssen, J., Verzijl, D., Witte, M., Ronken, E., Van Het Hof, B., Lakeman, K., Dijkstra, C. D., Van Der Valk, P., Reijerkerk, A., et al. (2010) · Glia · doi:10.1002/glia.21021 · Cited by 201
Cellular Elements of the Blood-Brain Barrier
Correale, J., & Villa, A. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0081-y · Cited by 194
Deafness and Stria Vascularis Defects in S1P2 Receptor-null Mice
Kono, M., Belyantseva, I. A., Skoura, A., Frolenkov, G. I., Starost, M. F., Dreier, J. L., Lidington, D., Bolz, S.-S., Friedman, T. B., Hla, T., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700370200 · Cited by 191
MacLennan, A. J., Carney, P. R., Zhu, W. J., Chaves, A. H., Garcia, J., Grimes, J. R., Anderson, K. J., Roper, S. N., & Lee, N. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01634.x · Cited by 187
Weiner, J. A., Hecht, J. H., & Chun, J. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980907)398:4<587::aid-cne10>3.0.co;2-5 · Cited by 183
Self-citationChun, J. J. M., & Brinkmann, V. (2011) · PubMed · Cited by 177
Self-citationThe Immunomodulator FTY720 Has a Direct Cytoprotective Effect in Oligodendrocyte Progenitors
Coelho, R. P., Payne, S. G., Bittman, R., Spiegel, S., & Sato-Bigbee, C. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123927 · Cited by 175
Toman, R. E., Payne, S. G., Watterson, K. R., Maceyka, M., Lee, N. H., Milstien, S., Bigbee, J. W., & Spiegel, S. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200402016 · Cited by 173
Wheeler, D., Bandaru, V. V. R., Calabresi, P. A., Nath, A., & Haughey, N. J. (2008) · Brain · doi:10.1093/brain/awn190 · Cited by 171 · cited 1×
“white matter [65] but an increased level of S1P in their cerebrospinal fluid [66].”
Pébay, A., Toutant, M., Prémont, J., Calvo, C., Venance, L., Cordier, J., Glowinski, J., & Tencé, M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01585.x · Cited by 171
How factors secreted from astrocytes impact myelin repair
Moore, C. S., Abdullah, S. L., Brown, A., Arulpragasam, A., & Crocker, S. J. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22482 · Cited by 171
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
Brück, W., Pförtner, R., Pham, T., Zhang, J., Hayardeny, L., Piryatinsky, V., Hanisch, U.-K., Regen, T., van Rossum, D., Brakelmann, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1009-1 · Cited by 168
Activation of sphingosine‐1‐phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration
Novgorodov, A. S., El‐Awani, M., Bielawski, J., Obeid, L. M., & Gudz, T. I. (2007) · The FASEB Journal · doi:10.1096/fj.06-7420com · Cited by 167
Weiner, J. A., Fukushima, N., Contos, J. J. A., Scherer, S. S., & Chun, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07069.2001 · Cited by 166
Self-citationKitano, M., Hla, T., Sekiguchi, M., Kawahito, Y., Yoshimura, R., Miyazawa, K., Iwasaki, T., & Sano, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21668 · Cited by 165
Central nervous system-directed effects of FTY720 (fingolimod)
Miron, V. E., Schubart, A., & Antel, J. P. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.031 · Cited by 164
Nayak, D., Huo, Y., Kwang, T. W., Pushparaj, P. N., Srinivasan, D. K., Ling, E., & Dheen, S. T. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.020 · Cited by 162
The blood–brain-barrier in multiple sclerosis: Functional roles and therapeutic targeting
Correale, J. D., & Villa, A. M. (2007) · Autoimmunity · doi:10.1080/08916930601183522 · Cited by 160
Tani, M., Ito, M., & Igarashi, Y. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.07.001 · Cited by 159
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells
Jung, C., Kim, H., Miron, V. E., Cook, S. P., Kennedy, T. E., Foster, C. A., Antel, J. P., & Soliven, B. C. (2007) · Glia · doi:10.1002/glia.20576 · Cited by 158
Balatoni, B., Storch, M. K., Swoboda, E.-M., Schönborn, V., Koziel, A., Lambrou, G. N., Hiestand, P. C., Weissert, R., & Foster, C. A. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.06.023 · Cited by 158
Foster, C. A., Mechtcheriakova, D., Storch, M. K., Balatoni, B., Howard, L. M., Bornancin, F., Wlachos, A., Sobanov, J., Kinnunen, A., & Baumruker, T. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00182.x · Cited by 156
Lysophosphatidic Acid Signaling May Initiate Fetal Hydrocephalus
Yung, Y. C., Mutoh, T., Lin, M., Noguchi, K., Rivera, R. R., Choi, J. W., Kingsbury, M. A., & Chun, J. J. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002095 · Cited by 156
Self-citationFingolimod modulates microglial activation to augment markers of remyelination
Jackson, S. J., Giovannoni, G., & Baker, D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-76 · Cited by 153
Lin, M., Rivera, R. R., & Chun, J. J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330183 · Cited by 152
Self-citationInvolvement of Sphingosine-1-Phosphate in Glutamate Secretion in Hippocampal Neurons
Kajimoto, T., Okada, T., Yu, H., Goparaju, S. K., Jahangeer, S. M., & Nakamura, S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01465-06 · Cited by 149
Absence of LPA1 Signaling Results in Defective Cortical Development
Estivill‐Torrús, G., Llebrez-Zayas, P., Matas-Rico, E., Santín, L. J., Pedraza, C., de Diego, I., del Arco, I., Fernández‐Llebrez, P., Chun, J. J. M., & de Fonseca, F. R. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm132 · Cited by 147
Self-citationZhang, G., Contos, J. J. A., Weiner, J. A., Fukushima, N., & Chun, J. J. M. (1999) · Gene · doi:10.1016/s0378-1119(98)00589-7 · Cited by 146
Self-citationPathophysiology of multiple sclerosis and the place of teriflunomide
Gold, R., & Wolinsky, J. S. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01444.x · Cited by 145
Czech-Zechmeister, B., Pfeilschifter, W., Mazaheri-Omrani, N., Strobel, M. A., Kahles, T., Neumann‐Haefelin, T., Rami, A., Huwiler, A., & Pfeilschifter, J. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.142 · Cited by 145
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors
Müllershausen, F., Craveiro, L. M., Shin, Y., Cortés-Cros, M., Bassilana, F., Osinde, M., Wishart, W. L., Guerini, D., Thallmair, M., Schwab, M. E., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04629.x · Cited by 142
Cytokines which signal through the LIF receptor and their actions in the nervous system
Murphy, M., Dutton, R., Koblar, S., Cheema, S., & Bartlett, P. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00020-8 · Cited by 138 · cited 1×
“Astrocytes are the most abundant cells in the human CNS and have anextremely diverse and important range of roles that are relevant to normal brain activity and its alteration in disease states [70–78].”
Insights into the pharmacological relevance of lysophospholipid receptors
Mutoh, T., Rivera, R. R., & Chun, J. J. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01622.x · Cited by 137
Self-citationStasiołek, M., Bayas, A., Kruse, N., Wieczarkowiecz, A., Toyka, K. V., Gold, R., & Selmaj, K. W. (2006) · Brain · doi:10.1093/brain/awl043 · Cited by 135
Microglial activation state and lysophospholipid acid receptor expression
Tham, C., Lin, F., Rao, T. S., Yu, N., & Webb, M. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2003.09.003 · Cited by 131
Thöne, J., Ellrichmann, G., Seubert, S., Peruga, I., Lee, D.-H., Conrad, R., Hayardeny, L., Comı, G., Wiese, S., Linker, R. A., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.037 · Cited by 131
Insight into the mechanism of laquinimod action
Brück, W., & Wegner, C. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.02.019 · Cited by 126
Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors
Siehler, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00142-7 · Cited by 126
Miller, R. H., & Mi, S. (2007) · Nature Neuroscience · doi:10.1038/nn1995 · Cited by 125
Yu, N., Lariosa-Willingham, K. D., Lin, F., Webb, M., & Rao, T. S. (2003) · Glia · doi:10.1002/glia.10297 · Cited by 124
Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors
Osinde, M., Müllershausen, F., & Dev, K. K. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.11.010 · Cited by 122
Wegner, C., Stadelmann, C., Pförtner, R., Raymond, E., Feigelson, S. W., Alon, R., Timan, B., Hayardeny, L., & Brück, W. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.07.009 · Cited by 121
Merrill, J. E., Hanak, S. E., Pu, S.-F., Liang, J., Dang, C., Iglesias-Bregna, D., Harvey, B., Zhu, B., & McMonagle-Strucko, K. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0075-3 · Cited by 119
Vacuolar Leukoencephalopathy with Widespread Astrogliosis in Mice Lacking Transcription Factor Nrf2
Hubbs, A. F., Benkovic, S. A., Miller, D. B., O'Callaghan, J. P., Battelli, L. A., Schwegler‐Berry, D., & Ma, Q. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060898 · Cited by 119
Zhu, D., Wang, Y., Singh, I., Bell, R. D., Deane, R., Zhong, Z., Sagare, A. P., Winkler, E. A., & Zloković, B. V. (2010) · Blood · doi:10.1182/blood-2010-01-262386 · Cited by 118
The Sphingosine‐1‐Phosphate Receptor Agonist FTY720 Modulates Dendritic Cell Trafficking In Vivo
Lan, Y. Y., Creus, A. D., Colvin, B. L., Abe, M., Brinkmann, V., Coates, P. T., & Thomson, A. W. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01085.x · Cited by 117
Herr, D. R., Grillet, N., Schwander, M., Rivera, R. R., Müller, U., & Chun, J. J. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4245-06.2007 · Cited by 115
Self-citationRadue, E. W., O'Connor, P., Polman, C. H., Hohlfeld, R., Calabresi, P., Selmaj, K., Mueller-Lenke, N., Agoropoulou, C., Holdbrook, F., de Vera, A., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1051 · Cited by 115
Fischer, I., Alliod, C., Martinier, N., Newcombe, J., Brana, C., & Pouly, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023905 · Cited by 113
Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis
Gao, Z., & Tsirka, S. E. (2011) · Neurology Research International · doi:10.1155/2011/383087 · Cited by 112
Piali, L., Froidevaux, S., Hess, P., Nayler, O., Bolli, M. H., Schlosser, E., Kohl, C., Steiner, B., & Clozel, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.176487 · Cited by 110
Soliven, B. C., Miron, V. E., & Chun, J. J. M. (2011) · Neurology · doi:10.1212/wnl.0b013e31820d9507 · Cited by 109
Self-citationNeurobiological effects of sphingosine 1‐phosphate receptor modulation in the cuprizone model
Kim, H. J., Miron, V. E., Dukala, D., Proia, R. L., Ludwin, S. K., Traka, M., Antel, J. P., & Soliven, B. C. (2011) · The FASEB Journal · doi:10.1096/fj.10-173203 · Cited by 108
Anelli, V., Bassi, R., Tettamanti, G., Viani, P., & Riboni, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02955.x · Cited by 107
Roles of glial cells in synapse development
Pfrieger, F. W. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0005-7 · Cited by 106
McGiffert, C., Contos, J. J. A., Friedman, B., & Chun, J. J. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03404-x · Cited by 106
Self-citationKorn, T., Magnus, T., Toyka, K. V., et al. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0504308 · Cited by 105
Edg-8 receptors are preferentially expressed in oligodendrocyte lineage cells of the rat CNS
Terai, K., Soga, T., Takahashi, M. P., Kamohara, M., Ohno, K., Yatsugi, S., Okada, M., & Yamaguchi, T. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00791-1 · Cited by 102
Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor
Dudek, S. M., Camp, S. M., Chiang, E. T., Singleton, P. A., Usatyuk, P. V., Zhao, Y., Natarajan, V., & Garcia, J. G. N. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.03.011 · Cited by 99
Wu, Y., Mizugishi, K., Bektas, M., Sandhoff, R., & Proia, R. L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn126 · Cited by 97
Cyclical and Dose-Dependent Responses of Adult Human Mature Oligodendrocytes to Fingolimod
Miron, V. E., Hall, J. A., Kennedy, T. E., Soliven, B. C., & Antel, J. P. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080478 · Cited by 96
Rao, T. S., Lariosa-Willingham, K. D., Lin, F., Palfreyman, E. L., Yu, N., Chun, J. J. M., & Webb, M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03527-3 · Cited by 94
Self-citationThe role of dendritic cells in CNS autoimmunity
Zozulya, A. L., Clarkson, B. D. S., Ortler, S., Fábry, Z., & Wiendl, H. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0607-4 · Cited by 93
Brain atrophy in multiple sclerosis: what we know and would like to know
Simon, J. H. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070823 · Cited by 89
Fingolimod protects cultured cortical neurons against excitotoxic death
Menna, L. D., Molinaro, G., di Nuzzo, L., Riozzi, B., Zappulla, C., Pozzilli, C., Turrini, R., Caraci, F., Copani, A., Battaglia, G., et al. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.004 · Cited by 84
Rossi, S., Giudice, T. L., Chiara, V. D., Musella, A., Studer, V., Motta, C., Bernardi, G., Martino, G., Furlan, R., Martorana, A., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01579.x · Cited by 82
Dubin, A. E., Bahnson, T. D., Weiner, J. A., Fukushima, N., & Chun, J. J. M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01371.1999 · Cited by 79
Self-citationLiu, J., Zhang, C., Tao, W., & Liu, M. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.749255 · Cited by 79
Fukushima, N., Shano, S., Moriyama, R., & Chun, J. J. M. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.09.008 · Cited by 77
Self-citationTargeting dendritic cells to treat multiple sclerosis
Comabella, M., Montalbán, X., Münz, C., & Lünemann, J. D. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.112 · Cited by 76
Neurons and Oligodendrocytes Recycle Sphingosine 1-Phosphate to Ceramide
Qin, J., Berdyshev, E. V., Goya, J., Natarajan, V., & Dawson, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.076810 · Cited by 76
Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis
Kułakowska, A., Żendzian‐Piotrowska, M., Baranowski, M., Konończuk, T., Drozdowski, W., Górski, J., & Bucki, R. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.052 · Cited by 75
Zhang, Y. H., Vasko, M. R., & Nicol, G. D. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.111575 · Cited by 73
Zhang, Z., Zhang, Z., Fauser, U., & Schluesener, H. J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.025 · Cited by 72
Aharoni, R., Saada, R., Eilam, R., Hayardeny, L., Sela, M., & Arnon, R. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.06.005 · Cited by 71
Maki, T., Gottschalk, R., Ogawa, N., & Monaco, A. P. (2005) · Transplantation · doi:10.1097/01.tp.0000161220.87548.ee · Cited by 68 · cited 1×
“fingolimod treatment also reversed diabetes in mice that were diabetic [159].”
Herr, K. J., Herr, D. R., Lee, C., Noguchi, K., & Chun, J. J. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106129108 · Cited by 67
Self-citationNorimatsu, Y., Ohmori, T., Kimura, A., Madoiwa, S., Mimuro, J., Seichi, A., Yatomi, Y., Hoshino, Y. Y., & Sakata, Y. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.12.012 · Cited by 67
Differential responses of human microglia and blood-derived myeloid cells to FTY720
Durafourt, B. A., Lambert, C., Johnson, T., Blain, M., Bar‐Or, A., & Antel, J. P. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.006 · Cited by 63
Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease
Luo, J., Ho, P. P.-K., Steinman, L., & Wyss‐Coray, T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-6 · Cited by 63
Fukushima, N., Ishii, I., Habara, Y., Allen, C. B., & Chun, J. J. M. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-09-0465 · Cited by 61
Self-citationSheridan, G. K., & Dev, K. K. (2011) · Glia · doi:10.1002/glia.22272 · Cited by 60
Astrocytes in the tempest of multiple sclerosis
Miljković, D. M., Timotijević, G. S., & Stojković, M. M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.047 · Cited by 60
Papadopoulos, D., Rundle, J., Patel, R., Marshall, I. C. B., Stretton, J. L., Eaton, R., Richardson, J. C., Gonzalez, M., Philpott, K. L., & Reynolds, R. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22196 · Cited by 60
Al‐Izki, S., Pryce, G., Jackson, S. J., Giovannoni, G., & Baker, D. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511400476 · Cited by 59
Hu, Y., Lee, X., Ji, B., Guckian, K. M., Apicco, D. J., Pepinsky, R. B., Miller, R. H., & Mi, S. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.06.007 · Cited by 59
Evaluation of Experimental Autoimmune Uveitis in Mice Treated with FTY720
Commodaro, A. G., Peron, J. P. S., Lopes, C. T., Arslanian, C., Belfort, R., Rizzo, L. V., & Bueno, V. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4769 · Cited by 57
Ruffini, F., Rossi, S., Bergamaschi, A., Brambilla, E., Finardi, A., Motta, C., Studer, V., Barbieri, F. R., Chiara, V. D., Hayardeny, L., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512469698 · Cited by 50
Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-β
Gao, Y., Majchrzak-Kita, B., Fish, E. N., & Gommerman, J. L. (2009) · Blood · doi:10.1182/blood-2008-10-183301 · Cited by 47
Akahoshi, N., Ishizaki, Y., Yasuda, H., Murashima, Y. L., Shinba, T., Goto, K., Himi, T., Chun, J. J. M., & Ishii, I. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.09.002 · Cited by 42
Self-citationSphingosine-1-phosphate receptors as emerging targets for treatment of pain
Welch, S. P., Sim‐Selley, L. J., & Selley, D. E. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.010 · Cited by 41
Zhang, Z., Zhang, Z., Fauser, U., Artelt, M., Burnet, M. W. M., & Schluesener, H. J. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00019.x · Cited by 41
Takeshita, H., Kitano, M., Iwasaki, T., Kitano, S., Tsunemi, S., Sato, C., Sekiguchi, M., Azuma, N., Miyazawa, K., Hla, T., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.103 · Cited by 40
Galicia, G., Pikor, N. B., Schwartz, J. A., Rojas, O. L., Jian, A., deLuca, L. S., Ostrowski, M., Nuesslein‐Hildesheim, B., & Gommerman, J. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102261 · Cited by 38
FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination
Kipp, M., & Amor, S. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512438723 · Cited by 37
Roles for lysophospholipid S1P receptors in multiple sclerosis
Noguchi, K., & Chun, J. J. M. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.522975 · Cited by 35
Self-citationLinker, R. A., Lee, D.-H., Stangel, M., & Gold, R. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.11.1683 · Cited by 34
Development of oral immunomodulatory agents in the management of multiple sclerosis
Nicholas, R. S., Nicholas, R. S., Giannetti, Alsanousi, A., & Muraro, P. A. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s10498 · Cited by 33
Rau, C. R., Hein, K., Sättler, M. B., Kretzschmar, B., Hillgruber, C., McRae, B. L., Diem, R., & Bähr, M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.003 · Cited by 32
Rao, T. S., Lariosa-Willingham, K. D., Lin, F., Yu, N., Tham, C., Chun, J. J. M., & Webb, M. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.03.005 · Cited by 31
Self-citationMoberly, J. B., Ford, D. M., Zahir, H., Chen, S., Mochizuki, T., Truitt, K. E., & Vollmer, T. L. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.007 · Cited by 30
Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy
Kim, H., Jung, C., Dukala, D., Bae, H., Kakazu, R., Wollmann, R. L., & Soliven, B. C. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.006 · Cited by 25
Popovic, J., Kover, K. L., & Moore, W. V. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00036.x · Cited by 21
Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies
Antel, J. P., & Miron, V. E. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2008.03.021 · Cited by 20
Ohno, T., Hasegawa, C., Nakade, S., Kitagawa, J., Honda, N., & Ogawa, M. (2010) · Biopharmaceutics & drug disposition · doi:10.1002/bdd.719 · Cited by 18
Emerging oral drugs for relapsing–remitting multiple sclerosis
Gasperini, C., & Ruggieri, S. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.642861 · Cited by 14
Cited by
Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain
Lake, B. B., Chen, S., Sos, B. C., Fan, J., Kaeser, G. E., Yung, Y. C., Duong, T. E., Gao, D., Chun, J., Kharchenko, P. V., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4038 · Cited by 983
Self-citationCodega, P., Silva-Vargas, V., Paul, A., Maldonado-Soto, A. R., DeLeo, A. M., Pastrana, E., & Doetsch, F. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.039 · Cited by 634
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets
Tschoe, C., Bushnell, C. D., Duncan, P. W., Alexander-Miller, M. A., & Wolfe, S. Q. (2020) · Journal of Stroke · doi:10.5853/jos.2019.02236 · Cited by 490
Lysophospholipid receptor nomenclature review: IUPHAR Review 8
Kihara, Y., Maceyka, M., Spiegel, S., & Chun, J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12678 · Cited by 324
Self-citation
Metadata
- Authors
- Groves, A., Kihara, Y., & Chun, J.
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 328
- Issue
- 1-2
- Pages
- 9-18
- ISSN
- 0022-510X (ISSN-L)
- OpenAlex
- W2170098900
- Cited by
- 314
- References
- 178
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.